$BBLG SEC Filings

Filed On	Filing
26 Oct 2026	10-Q
13 Oct 2026	25-NSE
30 Sep 2026	Form 4: Gagnon Robert E., Director Granted 113,896 Non-Employee Stock Option
30 Sep 2026	Form 4: Angle Siddhesh Rajendra, Director Granted 113,896 Non-Employee Stock Option
30 Sep 2026	Form 4: Meikle Phillip Terry Ii, Director Granted 113,896 Non-Employee Stock Option
30 Sep 2026	Form 4: Stroever Bruce, Director Granted 113,896 Non-Employee Stock Option
29 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders At the Annual Meeting of stockholders (the “Annual Meeting”) of Bone Biologics Corporation (the “Company”), held on September 28, 2026, the Company’s stockholders voted on the matters described below. The number of shares of common stock...
16 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
28 Aug 2026	Proxy statement: annual meeting on September 28, 2026 CEO pay $426K, up 11% · say-on-pay vote
18 Aug 2026	PRE 14A
14 Aug 2026	10-Q
24 Jul 2026	EFFECT
24 Jul 2026	424B3
23 Jul 2026	8-K: Regulation FD Disclosure
20 Jul 2026	DEFA14A
17 Jul 2026	S-3
16 Jul 2026	8-K: Other Events
09 Jul 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
02 Jul 2026	ARS
02 Jul 2026	DEFA14A

Comments